A study recently indicated that the pregnane X-receptor (PXR) pathway also includes irinotecan resistance in the colon cancer cell line through the upregulation of drug-metabolizing genes such as CYP3A4 [122–124]. This evidence concerns the gene NR1I2 and malignant colon neoplasm.